About Us
Our Mission
Our goal is to make gene knockdowns simple, efficient and fast.
At ADViRNA we strive to bring ease to your research projects. Whether you are new to RNAi or not, we are available to help find the best fit solutions for your experimental needs
In The Beginning
ADViRNA was founded in 2007 by Anastasia Khvorova, PhD and Alexey Wolfson, PhD.
Their mission was to make a new nucleic based technology for therapeutic research use.
They strive to provide researchers with the best tools to study and manipulate activity of genes.
Developing improved tools to manipulate and study the activity of genes in living cells
Our Team
-
Alexey Wolfson, PhD
Founder and CEO
-
Sean McCauley, PhD
Lead Scientist
-
Hannah McCauley
Sr. Research Associate
Business Operations Manager
-
Nicholas Rice, PhD
Scientist
-
Sarah Goudreau
Sr. Research Associate
-
Parixit Oza, MS
Research Associate, Oligo Synthesis
-
Kyle Foster, PhD
Scientist
Scientific Advisors
-
Anastasia Khvorova, PhD
Professor at University Massachusetts Medical School
-
Craig Mello, PhD
Nobel Prize Winner
Professor at University Massachusetts Medical School
-
Greg Hannon, PhD
Professor at University of Cambridge
Howard Hughes Medical Institute Investigator
-
Tod Wolf, PhD
Co-founder and former CEO RXI Pharmaceuticals
